Search research articles
Contact Us
Filters
Showing results (51-60 of 116) with videos related to
Page
of 12
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
July 21, 2020
Assessment of the anti-hyperalgesic efficacy of J-2156, relative to clinically available analgesic/adjuvant agents in a rat model of mild to moderate chronic mechanical low back pain (LBP)
Andy Kuo, Jacintha Lourdesamy, Janet R Nicholson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 3, 2016
High-throughput assay for quantification of the plasma concentrations of thiopental using automated solid phase extraction (SPE) directly coupled to LC-MS/MS instrumentation
Seyed Mojtaba Moosavi, Kiran Shekar, John Fraser, et al.
Frontiers in Pharmacology
|
July 23, 2016
Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
Felicity Y Han, Kristofer J Thurecht, Andrew K Whittaker, et al.
Inflammopharmacology
|
October 2, 2017
Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain
Nemat Khan, Andy Kuo, David A Brockman, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 22, 2018
Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy
Felicity Y Han, Andy Kuo, Janet R Nicholson, et al.
Pain Medicine (Malden, Mass.)
|
June 8, 2013
A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia
Maree T Smith, Trent M Woodruff, Bruce D Wyse, et al.
Journal of Medicinal Chemistry
|
March 1, 2023
Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects
Maree T Smith, Dehui Kong, Andy Kuo, et al.
Journal of Medicinal Chemistry
|
January 7, 2022
Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources
Maree T Smith, Dehui Kong, Andy Kuo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 18, 2017
An improved liquid chromatography tandem mass spectrometry (LC-MS/MS) method for quantification of dexmedetomidine concentrations in samples of human plasma
Seyed Mojtaba Moosavi, Kiran Shekar, John F Fraser, et al.
Pharmacological Reports : PR
|
July 28, 2020
Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain
Mohammad Zafar Imam, Andy Kuo, Janet R Nicholson, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 116) with videos related to
Sort By:
Page
of 12
Clinical and Experimental Pharmacology & Physiology
|
July 21, 2020
Assessment of the anti-hyperalgesic efficacy of J-2156, relative to clinically available analgesic/adjuvant agents in a rat model of mild to moderate chronic mechanical low back pain (LBP)
Andy Kuo, Jacintha Lourdesamy, Janet R Nicholson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 3, 2016
High-throughput assay for quantification of the plasma concentrations of thiopental using automated solid phase extraction (SPE) directly coupled to LC-MS/MS instrumentation
Seyed Mojtaba Moosavi, Kiran Shekar, John Fraser, et al.
Frontiers in Pharmacology
|
July 23, 2016
Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
Felicity Y Han, Kristofer J Thurecht, Andrew K Whittaker, et al.
Inflammopharmacology
|
October 2, 2017
Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain
Nemat Khan, Andy Kuo, David A Brockman, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 22, 2018
Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy
Felicity Y Han, Andy Kuo, Janet R Nicholson, et al.
Pain Medicine (Malden, Mass.)
|
June 8, 2013
A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia
Maree T Smith, Trent M Woodruff, Bruce D Wyse, et al.
Journal of Medicinal Chemistry
|
March 1, 2023
Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects
Maree T Smith, Dehui Kong, Andy Kuo, et al.
Journal of Medicinal Chemistry
|
January 7, 2022
Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources
Maree T Smith, Dehui Kong, Andy Kuo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 18, 2017
An improved liquid chromatography tandem mass spectrometry (LC-MS/MS) method for quantification of dexmedetomidine concentrations in samples of human plasma
Seyed Mojtaba Moosavi, Kiran Shekar, John F Fraser, et al.
Pharmacological Reports : PR
|
July 28, 2020
Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain
Mohammad Zafar Imam, Andy Kuo, Janet R Nicholson, et al.
Page
of 12